Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Qbrexza Generic Name & Formulations
Legal Class
Rx
General Description
Glycopyrronium 2.4% soln; per cloth (pre-moistened).
Pharmacological Class
Anticholinergic.
How Supplied
Single-use cloth—30
Manufacturer
Generic Availability
NO
Qbrexza Indications
Indications
Primary axillary hyperhidrosis.
Qbrexza Dosage and Administration
Adults and Children
<9yrs: not established. ≥9yrs: Using a single cloth, apply once daily to both axillae. Do not occlude.
Qbrexza Contraindications
Contraindications
Conditions that can be exacerbated by anticholinergic effect (eg, glaucoma, paralytic ileus, unstable cardiovascular status in acute hemorrhage, severe ulcerative colitis, toxic megacolon complicating ulcerative colitis, myasthenia gravis, Sjogren's syndrome).
Qbrexza Boxed Warnings
Not Applicable
Qbrexza Warnings/Precautions
Warnings/Precautions
History of documented urinary retention. Discontinue immediately if symptoms of urinary retention develop. Prostatic hypertrophy or bladder-neck obstruction. High ambient temperature. Advise patients to avoid use if generalized lack of sweating develops when exposed to hot/warm temperatures. Avoid other body areas, broken skin, contact with the eyes, or transfer to the periocular area. Flammable. Renal impairment. Pregnancy. Nursing mothers.
Qbrexza Pharmacokinetics
See Literature
Qbrexza Interactions
Interactions
Additive anticholinergic effects with other anticholinergic-containing drugs; avoid.
Qbrexza Adverse Reactions
Adverse Reactions
Dry mouth, mydriasis, oropharyngeal pain, headache, urinary hesitation, vision blurred, nasal dryness, dry throat/eye/skin, constipation, local skin reactions (eg, erythema, burning/stinging/pruritus).
Qbrexza Clinical Trials
See Literature
Qbrexza Note
Not Applicable
Qbrexza Patient Counseling
See Literature
Images
